Showing results (121-130 of 171) with videos related to
Sort By:
Pageof 18
Ecancermedicalscience|March 11, 2020
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease preventionJaqui Walker, Marco Cattaneo, Lina Badimon, et al.Diabetes Research and Clinical Practice|May 11, 2025
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover studyAlessandro Rizzi, Giovanna Petrucci, Monica Sacco, et al.Journal of the Heart Valve Society|November 28, 2025
Clinical and Hemodynamic Implications of Mitral Annular CalcificationAndrea Faggiano, Bianca Rocca, Chi Young Shim, et al.Blood|June 11, 2008
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patientsFrancesca Santilli, Mario Romano, Antonio Recchiuti, et al.Neurobiology of Aging|January 31, 2006
Determinants of platelet activation in Alzheimer's diseaseGiovanni Ciabattoni, Ettore Porreca, Concetta Di Febbo, et al.Platelets|July 14, 2005
Homocysteinemia is inversely correlated with platelet count and directly correlated with sE- and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductaseMauro Rongioletti, Mauro Baldassini, Fabrizio Papa, et al.Journal of Thrombosis and Haemostasis : JTH|July 19, 2024
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTHJerrold H Levy, Joseph R Shaw, Lana A Castellucci, et al.Research and Practice in Thrombosis and Haemostasis|December 19, 2024
Stability of the thromboxane B2 biomarker of low-dose aspirin pharmacodynamics in human whole blood and in long-term stored serum samplesGiovanna Petrucci, Alessandro Rizzi, Simone Bellavia, et al.Hemasphere|August 4, 2022
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With CancerAnna Falanga, Avi Leader, Chiara Ambaglio, et al.Thrombosis and Haemostasis|August 15, 2015
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient miceSilvia S Barbieri, Giovanna Petrucci, Eva Tarantino, et al.Pageof 18